Table 5. Review studies of different muscle relaxants and their role in multimodal analgesia.
AE: adverse effect
| Medication or class | Author | Recommended use | Contraindications and/or specific recommendations |
| Methocarbamol | Looke & Kluth 2013 [15], Patanwala et al. 2017 [7] | Muscle spasms, hip and knee replacements, trauma, and rib fractures | Renal impairment, methocarbamol is less sedating, has less psychological dependence potential, and has less significant withdrawal potential than other agents. |
| Cyclobenzaprine | Khwaja et al. 2010 [24] | Muscle spasms | AEs: cardiac arrhythmias, sedation, dizziness |
| Carisoprodol | Serfer et al. 2010 [25] | Muscle spasms | AEs: barbiturate-like effects |
| Baclofen | Pérez-Arredondo et al. 2016 [26] | Spasticity, spasticity with brain or spinal cord injuries | AEs: sedation, serious withdrawal (seizures), renal impairment |
| Tizanidine | Yazicioglu et al. 2016 [27] | Spasticity, muscle spasms | AEs: hepatotoxicity, withdrawal, renal impairment |
| Zolpidem | Hagan et al. 2020 [28] | Spasticity, muscle spasms | Benzodiazepines like effects |
| Ketamine | Patanwala et al. 2017 [29] | Severe post-operative pain, opioid tolerance, opioid-induced hyperalgesia, opioid-induced respiratory depression | AEs: hypersalivation, laryngospasm, hallucinations precautions; severe CV disease, pregnancy, active psychosis, elderly |
| Local and/or regional anesthesia | Choi et al. 2013 [30] | Perioperative pain management, rib or hip fracture | AEs: nerve injury, hypotension, hematoma relative contraindication; compartment syndrome, coagulopathy |